Jason Park

Jason Park has extensive experience in the life sciences industry, with a focus on founding and growing innovative companies. Jason is the current Chief Executive Officer of Empress Therapeutics, a position they have held since July 2022. Prior to this, Jason was a Partner at Flagship Pioneering, where they played a key role in conceiving, creating, and growing life science companies. Jason was also the CEO and Co-Founder of Empress Therapeutics, as well as the COO and Co-Founder of Sonata Therapeutics. Before joining Flagship Pioneering, Jason worked as a Project Leader at The Boston Consulting Group, where they gained exposure in healthcare, technology, and strategy. Jason was also a member of the BCG Scientist Network. Jason's work at BCG included leading projects on various topics such as R&D, investment strategy, manufacturing, due diligence, and global health. Prior to BCG, they held positions at Carigent Therapeutics and co-founded Things Are Common, LLC.

Jason Park holds a Ph.D. degree in Biomedical Engineering from Yale University. Jason also attended Yale School of Management as a cross-registrant, where they studied Accounting, Finance, Competitive Strategy, and Venture Capital. Prior to that, they obtained a Master's degree in Engineering & Applied Science and a Bachelor's degree in Biomedical Engineering, both from Yale University.